Document:

EX-10.1

 Exhibit 10.1 

 
 Executive Severance Agreement 

(Tier I) 
  

Weyerhaeuser Company 

 Contents 
  

 
  

					
	Article 1.	  	Term of This Agreement	  	1
			
	Article 2.	  	Definitions	  	1
			
	Article 3.	  	Participation and Continuing Eligibility under this Agreement	  	3
			
	Article 4.	  	Severance Benefits	  	3
			
	Article 5.	  	Form and Timing of Severance Benefits	  	6
			
	Article 6.	  	The Company’s Payment Obligation	  	6
			
	Article 7.	  	Dispute Resolution	  	7
			
	Article 8.	  	Outplacement Assistance	  	7
			
	Article 9.	  	Successors and Assignment	  	7
			
	Article 10.	  	Section 409A	  	8
			
	Article 11.	  	Miscellaneous	  	8

  
 - i - 

 Weyerhaeuser Company 

Devin W. Stockfish (Executive) 
 Severance Agreement
(Tier I) 
 THIS EXECUTIVE SEVERANCE AGREEMENT (Tier I) is made and entered into by and between Weyerhaeuser Company (hereinafter
referred to as the “Company”) and Devin W. Stockfish (hereinafter referred to as the “Executive”) shall be effective January 1, 2019, or such other date on which Mr. Stockfish assumes the position of president and chief
executive officer of the Company (“Effective Date”). 
 Article 1. Term of This Agreement 

This Agreement shall commence on the Effective Date and shall terminate on December 31, 2019; provided, however, that commencing on
December 31, 2019 and each December 31 thereafter, the term of this Agreement shall be automatically extended for one additional year unless, not later than thirty (30) calendar days prior to such December 31, the Company or
Executive shall have given notice that such party does not wish to extend the term of this Agreement. 
 Article 2. Definitions 

Whenever used in this Agreement, the following terms shall have the meanings set forth below and, when the meaning is intended, the initial
letter of the word is capitalized: 
  

	 	(a)	 “Agreement” means this Executive Severance Agreement (Tier I). 

 

	 	(b)	 “Base Salary” means the salary of record paid to the Executive as annual salary, excluding
amounts received under incentive or other bonus plans, whether or not deferred. 

  

	 	(c)	 “Beneficiary” means the persons or entities designated or deemed designated by an Executive
pursuant to Section 11.2. 

  

	 	(d)	 “Board” means the Board of Directors of the Company. 

 

	 	(e)	 “Cause” means the Executive’s: 

 

	 	(i)	 Willful and continued failure to perform substantially the Executive’s duties with the Company after the
Company delivers to the Executive written demand for substantial performance specifically identifying the manner in which Executive has not substantially performed the Executive’s duties; 

 

	 	(ii)	 Conviction of a felony; or 

 

	 	(iii)	 Willfully engaging in illegal conduct or gross misconduct which is materially and demonstrably injurious to the
Company. 

 For purposes of this Section 2(e), no act or omission by the Executive shall be considered
“willful” unless it is done or omitted in bad faith or without reasonable belief that the Executive’s 

  
 -1- 

 
action or omission was in the best interests of the Company. Any act or failure to act based upon (A) authority given pursuant to a resolution duly adopted by the Board or (B) advice of
counsel for the Company shall be conclusively presumed to be done or omitted to be done by the Executive in good faith and in the best interests of the Company. For purposes of subsections (i)-(iii) above, the Executive shall not be deemed to
be terminated for Cause unless and until there shall have been delivered to the Executive a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters (3/4) of the entire membership of the Board at a meeting
called and held for such purpose (after reasonable notice is provided to the Executive and the Executive is given an opportunity, together with counsel, to be heard before the Board) finding that in the good faith opinion of the Board, the Executive
is guilty of the conduct described in subsection (i) or (iii) above and specifying the particulars thereof in detail. 
  

	 	(f)	 “CIC” of the Company shall have the definition set forth in the CIC Agreement.

  

	 	(g)	 “CIC Agreement” means the Executive Change in Control Agreement between the Company and the
Executive, as such agreement may be amended, supplemented or otherwise modified from time to time, or, if such agreement is no longer in effect, any successor agreement thereto. 

 

	 	(h)	 “Code” means the United States Internal Revenue Code of 1986, as amended.

  

	 	(i)	 “Committee” means the Compensation Committee of the Board, or any other committee appointed by
the Board to perform the functions of the Compensation Committee. 

  

	 	(j)	 “Company” means Weyerhaeuser Company, a Washington corporation (including any and all
subsidiaries), or any successor thereto as provided in Article 9. 

  

	 	(k)	 “Disability” shall have the meaning ascribed to it in the Company’s Retirement Plan for
Salaried Employees, or in any successor to such plan. 

  

	 	(l)	 “Effective Date” shall have the meaning ascribed to it in the preamble to this Agreement.

  

	 	(m)	 “Effective Date of Termination” means the date on which a Qualifying Termination occurs that
triggers the payment of Severance Benefits hereunder. 

  

	 	(n)	 “Executive” means a key executive of the Company who has been presented with and signed this
Agreement. 

  

	 	(o)	 “Non-Competition and Release Agreement” is an agreement, in substantially the form attached
hereto in Annex A, executed by and between the Executive and the Company as a condition to the Executive’s receipt of Severance Benefits. 

  

	 	(p)	 “Person” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange
Act and used in Sections 13(d) and 14(d) thereof, including a “group” as defined in Section 13(d). 

  

	 	(q)	 “Qualifying Termination” means any of the events described in Section 4.2, the occurrence
of which triggers the payment of Severance Benefits under Section 4.3. 

  
 -2- 

	 	(r)	 “Retirement” shall mean early or normal retirement under the Company’s Retirement Plan
for Salaried Employees. 

  

	 	(s)	 “Severance Benefits” means Severance Benefits described in Section 4.3.

 Article 3. Participation and Continuing Eligibility under this Agreement 

3.1 Participation. Subject to Section 3.2, as well as the remaining terms of this Agreement, the Executive shall remain eligible to
receive benefits hereunder during the term of this Agreement. 
 3.2 Removal From Coverage. In the event the Executive’s job
classification is reduced below the minimum level required for eligibility to continue to be covered by severance protection as determined at the sole discretion of the Committee, the Committee may remove the Executive from coverage under this
Agreement. Such removal shall be effective three (3) months after the date the Company notifies the Executive of such removal. 
 Article 4.
Severance Benefits 
 4.1 Right to Severance Benefits. 
  

	 	(a)	 Subject to Section 4.1(b), the Executive shall be entitled to receive from the Company Severance Benefits,
if the Executive’s employment with the Company shall end for any reason specified in Section 4.2, and the Executive is not (i) offered Comparable Employment by the Company or any subsidiary or affiliate of the Company whether in a
salaried, hourly, temporary or full-time capacity, or (ii) offered a contract to serve as a consultant or contractor by the Company or any subsidiary or affiliate of the Company containing terms and conditions reasonably deemed to be Comparable
Employment, or (iii) offered Comparable Employment or a contract to serve as a consultant or contractor by an entity acquiring assets of the Company or the business in which the Executive was employed containing terms and conditions reasonably
deemed to be Comparable Employment. 

  

	 	(b)	 If the Executive’s employment with the Company is terminated as a result of the acquisition (either
through the sale of assets or the sale of stock) or the outsourcing of the services previously provided internally by Company employees of the unit in which the Executive was employed, and the Executive is offered Comparable Employment by the
acquiring entity, the Executive is not eligible to receive Severance Benefits hereunder. 

 The Executive is not eligible
to receive both severance benefits under the CIC Agreement and Severance Benefits hereunder. Accordingly, if the Executive receives severance benefits under the CIC Agreement, he shall not receive Severance Benefits hereunder. However, if the
Executive suffers a Qualifying Termination, and if the Company has undergone a CIC such that the Executive’s Effective Date of Termination falls within the window period described in Section 4.2 of the CIC Agreement, the Executive’s
total Severance Benefits shall equal the amounts described as severance benefits under the CIC Agreement (potentially requiring additional payments to the extent the amounts already paid as Severance Benefits hereunder do not equal the amounts
payable as severance benefits under the CIC Agreement). 

  
 -3- 

	 	(c)	 Comparable Employment for purposes of paragraphs 4.1(a) and (b) above means employment terms that do not:

  

	 	(i)	 result in a material reduction in the Executive’s authority, duties or responsibilities existing
immediately prior to the termination; 

  

	 	(ii)	 require the Executive to be based at a location that is at least 50 miles farther from the Executive’s
primary residence immediately prior to the termination than is such residence from the Executive’s business location immediately prior to the termination, except for required travel on the Company’s business to an extent substantially
consistent with the Executive’s business obligations immediately prior to the termination; 

  

	 	(iii)	 include a material reduction in the Executive’s annual salary, benefits coverage in the aggregate, or
level of participation in the Company’s short- or long-term incentive compensation plans available to the Executive immediately prior to the termination; provided, however, that the reductions in the level of benefits coverage or participation
in incentive compensation plans shall be considered to be Comparable Employment if such reductions are substantially consistent with the average level of benefits coverage or participation in incentive plans of other executive officers with
positions commensurate with the Executive’s position at the Company, its subsidiary or the acquiring company. 

4.2 Qualifying Termination. An involuntary termination of the Executive’s employment by the Company, authorized by the
Company’s Senior Vice President of Human Resources, for reasons other than Cause, mandatory Retirement under the Company’s applicable policies, or the Executive’s death, Disability, or voluntary termination of employment (whether by
Retirement or otherwise) at any time other than within twenty-four (24) full calendar months following the effective date of a CIC shall trigger the payment of Severance Benefits to the Executive under this Agreement. 

4.3 Description of Severance Benefits. Subject to the conditions of Section 4.6, in the event that the Executive becomes entitled
to receive Severance Benefits, as provided in Sections 4.1 and 4.2, the Company shall pay to the Executive and provide him with the following: 
  

	 	(a)	 An amount equal to two (2) times the highest rate of the Executive’s annualized Base Salary rate in
effect at any time up to and including the Effective Date of Termination. 

  

	 	(b)	 An amount equal to two (2) the Executive’s target annual bonus established for the bonus plan year in
which the Executive’s Effective Date of Termination occurs. 

  

	 	(c)	 An amount equal to the Executive’s unpaid Base Salary and accrued vacation pay through the last day the
Executive worked. 

  

	 	(d)	 An amount equal to the Executive’s unpaid actual annual bonus, paid for the plan year in which the
Executive’s Effective Date of Termination occurs, multiplied by a fraction, the numerator of which is the number of days completed in then-existing fiscal year through the Effective Date of Termination and the denominator of which is three
hundred sixty-five (365). Any payments hereunder are in lieu of bonuses otherwise payable under the Company’s applicable annual incentive plans. 

  
 -4- 

	 	(e)	 A lump sum payment of ten thousand dollars ($10,000) (net of required payroll and income tax withholding) in
order to assist the Executive in paying for replacement health and welfare coverage for a reasonable period following the Executive’s Effective Date of Termination. 

4.4 Termination for Cause or by the Executive. If the Executive’s employment is terminated either (i) by the Company for
Cause or (ii) by the Executive, the Company shall pay the Executive his full Base Salary and accrued vacation through the last day worked, at the rate then in effect, plus all other amounts to which the Executive is entitled under any
compensation plans of the Company, at the time such payments are due, and the Company shall have no further obligations to the Executive under this Agreement. 

4.5 Notice of Termination. Any termination by the Company under this Article 4 shall be communicated by a Notice of Termination, which
shall be delivered to the Executive no later than the Effective Date of Termination, unless the Executive is terminated for Cause, in which case no Notice of Termination is required. For purposes of this Agreement, a “Notice of
Termination” shall mean a written notice that shall indicate the specific termination provision in this Agreement relied upon, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of
the Executive’s employment under the provision so indicated. 
 4.6 Delivery of Non-Competition and Release Agreement. The
payment of Severance Benefits is conditioned on the Executive’s timely execution of the Non-Competition and Release Agreement. The Company will deliver the Non-Competition and Release Agreement when it provides a Notice of Termination to the
Executive. The Non-Competition and Release Agreement shall be deemed effective upon the expiration of the required waiting periods under any applicable state and/or federal laws, as more specifically described therein. 

To support the enforcement of the Non-Competition and Release Agreement, the parties agree that the minimum value of the Non-Competition and
Release Agreement at the time this Agreement was entered into was at least 1.5 times the Executive’s Base Salary which has been built into the severance formula contained in Section 4.3. 

4.7 Removal From Representative Boards. In the event the terminating the Executive occupies any board of directors seats solely as a
Company representative, as a condition to receiving the severance set forth in Section 4.3, the Executive shall immediately resign such position upon his termination of employment with the Company and in any event by the deadline for returning
the Non-Competition and Release Agreement described in Section 4.6, unless specifically requested in writing by the Company otherwise. 
 Article 5.
Form and Timing of Severance Benefits 
 5.1 Form and Timing of Severance Benefits. The Severance Benefits described in
Sections 4.3(a), (b), (c) and (e) shall be paid in cash to the Executive in a single lump sum, subject to the Non-Competition and Release Agreement described in Section 4.6, as soon as practicable following the Effective Date of
Termination, but in no event beyond thirty (30) days from the later of the Effective Date of Termination and the successful expiration of the waiting periods described in Section 4.6 and in no event later than the payment deadline for
short-term deferrals under Treas. Reg. 

  
 -5- 

 
§ 1.409A-1(b)(4) (or any successor provision). The Severance Benefit described in Section 4.3(d) shall be paid in cash to the Executive in a single lump sum, subject to the
Non-Competition and Release Agreement described in Section 4.6, as soon as practicable following the end of the year in which the Executive’s Effective Date of Termination occurs and in no event later than the payment deadline for
short-term deferrals under Treas. Reg. § 1.409A-1(b)(4) (or any successor provision), subject to any deferral election by the Executive under an available deferred compensation plan that is applicable to such amount. 

5.2 Withholding of Taxes. The Company shall be entitled to withhold from any amounts payable under this Agreement all taxes as legally
shall be required (including, without limitation, any United States federal taxes and any other state, city, or local taxes). 
 Article 6. The
Company’s Payment Obligation 
 6.1 Payment Obligations Absolute. Except as provided in this Article 6 and in Article 7, the
Company’s obligation to make the payments and the arrangements provided for herein shall be absolute and unconditional, and shall not be affected by any circumstances, including, without limitation, any offset, counterclaim, recoupment,
defense, or other right that the Company may have against the Executive or anyone else. All amounts payable by the Company hereunder shall be paid without notice or demand. Except as provided in this Article 6 and in Article 7, each and every
payment made hereunder by the Company shall be final, and the Company shall not seek to recover all or any part of such payment from the Executive or from whosoever may be entitled thereto, for any reasons whatsoever. 

6.2 Contractual Rights to Benefits. Subject to Sections 3.2 and 6.3, this Agreement establishes and vests in the Executive a
contractual right to the benefits to which he may become entitled hereunder. However, nothing herein contained shall require or be deemed to require, or prohibit or be deemed to prohibit, the Company to segregate, earmark, or otherwise set aside any
funds or other assets, in trust or otherwise, to provide for any payments to be made or required hereunder. 
 6.3 Forfeiture of
Severance Benefits and Other Payments. Notwithstanding any other provision of this Agreement to the contrary, if it is determined by the Company that the Executive has violated any of the restrictive covenants contained in the Executive’s
Non-Competition and Release Agreement, the Executive shall be required to repay to the Company an amount equal to the economic value of all Severance Benefits and other payments already provided to the Executive under this Agreement and the
Executive shall forever forfeit the Executive’s rights to any unpaid Severance Benefits and other payments hereunder. Additional forfeiture provisions may apply pursuant to other agreements and policies between the Executive and the Company,
and any such forfeiture provisions shall remain in full force and effect. 
 Article 7. Dispute Resolution 

7.1 Claims Procedure. The Executive may file a written claim with the Company’s Senior Vice President of Human Resources, who shall
consider such claim and notify the Executive in writing of his decision with respect thereto within ninety (90) days (or within such longer period not to exceed one hundred eighty (180) days, as the Senior Vice President of Human Resources
determines is necessary to review the claim, provided that the Senior Vice President of Human Resources notifies the Executive in writing of the extension within the original ninety (90) day period). If the claim is denied, in whole or in part,
the Executive may appeal such denial to the 

  
 -6- 

 
Committee, provided the Executive does so in writing within sixty (60) days of receiving the determination by the Senior Vice President of Human Resources. The Committee shall consider the
appeal and notify the Executive in writing of its decision with respect thereto within sixty (60) days (or within such longer period not to exceed one hundred twenty (120) days as the Committee determines is necessary to review the appeal,
provided that the Committee notifies the Executive in writing of the extension within the original sixty (60) day period). 
 7.2
Finality of Determination. The determination of the Committee with respect to any question arising out of or in connection with the administration, interpretation, and application of this Agreement shall be final, binding, and conclusive on all
persons and shall be given the greatest deference permitted by law. 
 Article 8. Outplacement Assistance 

Following a Qualifying Termination (as described in Section 4.2), the Executive shall be reimbursed by the Company for the costs of all
outplacement services obtained by the Executive within the two (2) year period after the Effective Date of Termination; provided, however, that the total reimbursement shall be limited to twenty thousand dollars ($20,000) and shall be completed
by the end of the calendar year in which such two (2) year period expires. 
 Article 9. Successors and Assignment 

9.1 Successors to the Company. This Agreement shall be binding on the successors of the Company. 

9.2 Assignment by the Executive. This Agreement shall inure to the benefit of and be enforceable by each the Executive’s personal
or legal representatives, executors, administrators, successors, heirs, distributees, devisees, and legatees. If the Executive dies while any amount would still be payable to him hereunder had he continued to live, all such amounts, unless otherwise
provided herein, shall be paid in accordance with the terms of this Agreement to the Executive’s Beneficiary. If the Executive has not named a Beneficiary, then such amounts shall be paid to the Executive’s devisee, legatee, or other
designee, or if there is no such designee, to the Executive’s estate. 
 Article 10. Section 409A 

All Severance Benefits and reimbursements payable under this Agreement are intended to comply with the “short term deferral”
exception specified in Treas. Reg. § 1.409A-1(b)(4) (or any successor provision), or otherwise be excepted from coverage under Section 409A of the Code (“Section 409A”). Notwithstanding the foregoing sentence, to the extent an
exception is not available and the Executive must be treated as a “specified employee” within the meaning of Section 409A, any such amounts payable in cash and due to the Executive on or within the six (6) month period following
the Executive’s separation from service (as defined for purposes of Section 409A) will accrue during such six (6) month period and will become payable in a lump sum payment on the date six (6) months and one (1) day
following the date of the Executive’s separation from service; provided, however, that such payments will be paid earlier, at the times and on the terms set forth in the applicable provisions of this Agreement, if the Company reasonably
determines that the imposition of additional tax under Section 409A will not apply to an earlier payment of such payments. In addition, this Agreement will be interpreted, operated, and administered by the Company to the extent deemed
reasonably necessary to avoid imposition of any additional tax or 

  
 -7- 

 
income recognition prior to actual payment to the Executive under Section 409A, including any temporary or final treasury regulations and guidance promulgated thereunder. 

Article 11. Miscellaneous 
 11.1
Employment Status. Except as may be provided under any other agreement between the Executive and the Company, the employment of the Executive by the Company is “at will,” and may be terminated by either the Executive or the Company at
any time, subject to applicable law. 
 11.2 Beneficiaries. The Executive may designate one or more persons or entities as the
primary and/or contingent Beneficiaries of any Severance Benefits owing to the Executive under this Agreement. Such designation must be in the form of a signed writing acceptable to the Committee and pursuant to such other procedures as the
Committee may decide. If no such designation is on file with the Company at the time of the Executive’s death, or if no designated Beneficiaries survive the Executive for more than fourteen (14) days, any Severance Benefits owing to the
Executive under this Agreement shall be paid to the Executive’s estate. 
 11.3 Gender and Number. Except where otherwise
indicated by the context, any masculine term used herein also shall include the feminine, the plural shall include the singular, and the singular shall include the plural. 

11.4 Severability. In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or
invalidity shall not affect the remaining parts of this Agreement, and this Agreement shall be construed and enforced as if the illegal or invalid provision had not been included. Further, the captions of this Agreement are not part of the
provisions hereof and shall have no force and effect. 
 11.5 Modification. Except as provided in Article 1 and Section 3.2, no
provision of this Agreement may be modified, waived, or discharged following the Effective Date of Termination unless such modification, waiver, or discharge is agreed to in writing and signed by the Executive and by an authorized member of the
Committee, or by the respective parties’ legal representatives and successors. 
 11.6 Effect of Agreement. This Agreement shall
completely supersede and replace any and all portions of any contracts, plans, provisions, or practices pertaining to severance entitlements owing to the Executive from the Company other than the CIC Agreement, and is in lieu of any notice
requirement, policy, or practice. As such, the Severance Benefits described herein shall serve as the Executive’s sole recourse with respect to termination of employment by the Company other than a termination that entitles the Executive to
severance benefits under the terms of the CIC Agreement. In addition, Severance Benefits shall not be counted as “compensation,” or any equivalent term, for purposes of determining benefits under other agreements, plans, provisions, or
practices owing to the Executive from the Company, except to the extent expressly provided therein. Except as otherwise specifically provided for in this Agreement, the Executive’s rights under all such agreements, plans, provisions, and
practices continue to be subject to the respective terms and conditions thereof. 
 11.7 Applicable Law. To the extent not preempted
by the laws of the United States, the laws of the state of Washington shall be the controlling law in all matters relating to this Agreement. 

  
 -8- 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the dates appearing below.

  

			
	 Weyerhaeuser Company
  

By: /s/ Denise
Merle                                

Name: Denise Merle
 Its: Senior Vice President and Chief
Administration Officer
 Date: August 24, 2018
	  	 Executive
  

By: /s/ Devin W.
Stockfish                            

Name: Devin W. Stockfish
 Date: August 24, 2018

  
 -9- 

 ANNEX A 

NON-COMPETITION AND RELEASE AGREEMENT 

FOR THE EXECUTIVE SEVERANCE AGREEMENT (TIER I) 
  

	1.	 Parties. 

The parties to this Non-Competition and Release Agreement are Devin W. Stockfish (the “Executive”), and WEYERHAEUSER COMPANY, a
Washington corporation, and all successors thereto (“Company”). 
  

	2.	 Date. 

The date of this Non-Competition and Release Agreement (this “Release Agreement”) is
                                ,
20         (the “Date of this Agreement”). 
  

	3.	 Recitals. 

Executive’s employment with Company is ending. Executive is a participant in the Weyerhaeuser Company Executive Severance Agreement (Tier
I) (“Severance Agreement”) and is eligible for Severance Benefits under the Severance Agreement on condition Executive executes a non-competition and release agreement. This Release Agreement sets forth the terms of Executive’s
severance from Company. 
  

	4.	 Defined Terms. 

When defined terms from the Severance Agreement are used herein, they shall have the same definitions as provided in Article 2 of the Severance
Agreement. 
  

	5.	 Termination of Employment. 

Effective
                                ,
20        , Executive’s employment with Company shall terminate (“Termination Date”). Executive shall resign all positions with Company, whether as an officer, employee, or agent, in each
case effective on the Termination Date. 
  

	6.	 Payments. 

Upon expiration of the Revocation Period, defined below, without exercise of the right to revoke, Executive shall receive or be entitled to
receive the Severance Benefits and other payments to the extent set forth in the Severance Agreement, including, but not limited to, the forfeiture provisions of Section 6.3 thereof. 

  
 A-1 

	7.	 Release. 

Executive hereby releases Company, and all successors, subsidiaries, and affiliates of Company, and all officers, directors, employees, agents,
and shareholders of Company, and each of them, from any and all claims, liability, demands, rights, damages, costs, attorneys’ fees, and expenses of whatever nature that exist as of the date of execution of this Release Agreement, whether known
or unknown, foreseen or unforeseen, asserted or unasserted, including, but not limited to, all claims arising out of Executive’s employment and/or Executive’s termination from employment, and including all claims arising out of applicable
state and federal laws, Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the Employee Retirement Income Security Act of 1974, state and federal Family Leave Acts, and any other
applicable tort, contract, or other common law theories; provided, however, that this release shall not extend to any compensatory payments or other benefits due to Executive following the expiration of the Revocation Period pursuant to the terms
and conditions of any applicable benefit plans, programs and agreements maintained by Company for the benefit of Executive or to which Company and Executive are parties. 
  

	8.	 Confidentiality Agreement. 

8.1 Company’s Confidential Information. During the course of performing Executive’s duties as a Company employee, Executive
was exposed to and acquired Company’s Confidential Information. As used herein, “Confidential Information” refers to any and all information of a confidential, proprietary, or trade secret nature that is maintained in confidence by
Company for the protection of its business. Confidential Information includes, but is not limited to, Company’s information about or related to (i) any current or planned products, (ii) research and development or investigations
related to prospective products, (iii) proprietary software and systems, (iv) suppliers or customers, (v) cost information, profits, sales information, and accounting and unpublished financial information, (vi) business and
marketing plans and methods, and (vii) any other information not generally known to the public that, if misused or disclosed to a competitor, could reasonably be expected to adversely affect the Company. 

8.2 Nondisclosure of Confidential Information. Executive acknowledges that the Confidential Information is a special, valuable, and
unique asset of Company. Executive agrees to keep in confidence and trust all Confidential Information for so long as such information (i) is not generally known to the public or to persons outside Company who could obtain economic value
from its use and (ii) is subject to efforts by Company that are reasonable under the circumstances to maintain its secrecy. Executive agrees that Executive will not directly or indirectly use the Confidential Information for the benefit of
Executive or any other person or entity. 
  

	9.	 Nonsolicitation. 

9.1 Nonsolicitation of Employees. Executive agrees that for a period of two (2) years following the Termination Date, Executive
shall not directly or indirectly solicit or attempt to induce any employee of Company, any successor corporation, or a subsidiary of Company to work for Executive or any competing company or competing business organization. 

9.2 Nonsolicitation of Customers and Vendors. Executive agrees that for a period of two (2) years following the Termination Date,
Executive shall not directly or indirectly solicit or attempt to induce any customer, vendor, or supplier of Company to end its relationship with Company and/or conduct business with Executive or any entity in which Executive has a financial
interest. 

  
 A-2 

	10.	 Non-competition. 

Executive agrees that for a period of one (1) year following the Termination Date, Executive shall not directly or indirectly, whether as
an employee, officer, director, shareholder, agent, or consultant, engage or participate in any business that competes with Company, provided that nothing in this Section 10 shall preclude Executive from (i) performing any services on
behalf of an investment banking, commercial banking, auditing, or consulting firm or (ii) investing five percent (5%) or less in the common stock of any publicly traded company, provided such investment does not give Executive the right or
ability to control or influence the policy decisions of any competing business. 
  

	11.	 Review and Rescission Rights. 

Executive has forty-five (45) days from the Date of this Agreement (the “Review Period”) within which to decide whether to sign
this Release Agreement. If Executive signs this Release Agreement, Executive may revoke this Release Agreement if, within seven (7) days after signing (the “Revocation Period”), Executive delivers notice in writing to an Executive
Compensation Manager of Company. 
 This Release Agreement will not become effective, and the Severance Benefits dependent on the execution
of this Release Agreement will not become payable, until this Release Agreement is signed, the Revocation Period expires, and Executive has not exercised the right to revoke this Release Agreement. 

Executive may sign this Release Agreement prior to the end of the forty-five (45) day Review Period, thereby commencing the seven
(7) day Revocation Period. Whether Executive decides to sign before the end of the Review Period is entirely up to Executive. 

Executive will receive the same severance payments regardless of when Executive signs this Release Agreement, as long as Executive signs prior
to the end of the Review Period and does not revoke this Release Agreement. 
 Executive acknowledges that Executive’s release of
rights is in exchange for Severance Benefits to which Executive otherwise legally would not be entitled. 
  

	12.	 Advice of Counsel. 

Executive acknowledges that Executive has been advised to consult with an attorney before signing this Release Agreement. 

 

	13.	 Disputes. 

Any dispute or claim that arises out of or relates to this Release Agreement shall be resolved in accordance with the provisions of Article 7
of the Severance Agreement. Notwithstanding the provisions of this Section 13, any claim by Company for injunctive relief under the provisions of Section 8, 9, or 10 herein, or any subparts thereof, shall not be subject to the terms of
this Section 13. 

  
 A-3 

	14.	 Governing Law; Venue. 

To the extent not preempted by the laws of the United States, Washington law governs this Release Agreement, notwithstanding its choice of law
rules. Each of the parties submits to the exclusive jurisdiction of any state or federal court sitting in King County, Washington in any action or dispute arising out of or relating to this Release Agreement and agrees that all claims in respect of
such action or dispute may be heard and determined in any such court. Each party also agrees not to bring any action or proceeding arising out of or relating to this Release Agreement in any other court. Each of the parties waives any defense of
inconvenient forum to the maintenance of any action or dispute so brought and waives any bond, surety, or other security that might be required of any other party with respect thereto. 

 

	15.	 Entire Agreement. 

All of the parties’ agreements, covenants, representations, and warranties, express or implied, oral or written, concerning the subject
matter of this Release Agreement are contained in this Release Agreement. All prior and contemporaneous conversations, negotiations, agreements, representations, covenants, and warranties concerning the subject matter of this Release Agreement are
merged into this Release Agreement. This is an integrated agreement. 
  

	16.	 Miscellaneous. 

The benefits and obligations of this Release Agreement shall inure to the successors and assigns of the parties. The parties acknowledge that
the only consideration for this Release Agreement is the consideration expressly described herein, that each party fully understands the meaning and intent of this Release Agreement, that this Release Agreement has been executed voluntarily, and
that the terms of this Release Agreement are contractual. 
  

	17.	 Severability. 

Executive agrees that each provision in this Release Agreement will be treated as a separate and independent clause, and the enforceability of
any one clause will in no way impair the enforceability of any of the other clauses in this Release Agreement. Moreover, if one or more of the provisions contained in this Release Agreement, whether for the benefit of Executive or Company, are for
any reason held to be excessively broad as to scope, activity, or subject so as to be unenforceable at law, such provision or provisions will be construed by limiting and reducing it or them, so as to be enforceable to the maximum extent compatible
with the applicable law as it then appears. 
  

	18.	 Section and Paragraph Titles. 

Section and paragraph titles in this Release Agreement are used for convenience only and are not intended to and shall not in any way enlarge,
define, limit, or extend the rights or obligations of the parties or affect the interpretation of this Release Agreement. 

  
 A-4 

 WEYERHAEUSER COMPANY 
  

							
	By:	 	  
	 	Date:	 	  

	Title:	 	  
	 		 	

 Devin W. Stockfish 
  

							
	President and CEO	 	  
	 	Date:	 	  

  
 A-5EX-10.2

 Exhibit 10.2 

August 24, 2018 
 Adrian M. Blocker 

220 Occidental Ave. S. 
 Seattle, Washington 98104 

Dear Adrian: 
 As you know, the Weyerhaeuser Company
(“Weyerhaeuser”) Board of Directors has approved changes to the senior leadership of Weyerhaeuser as a result of the impending retirement of Doyle Simons from the offices of President and Chief Executive Officer, and you have been
appointed Senior Vice President of Timberlands. Because you are taking on an increased scope of responsibility and will continue to be a critical resource to Weyerhaeuser during and after the leadership transition, we are pleased to offer you a
grant of restricted stock units, as more specifically set forth below in this letter agreement (this “Agreement”). Capitalized terms used but not otherwise defined herein have the meanings given to such terms in the Weyerhaeuser
Company 2013 Long-Term Incentive Plan (the “Plan”). 
 1. Grant. In connection with your new appointment and responsibilities,
effective as of the date hereof Weyerhaeuser hereby makes to you under the Plan a one-time grant of restricted stock units (the “Grant”) as follows: 
  

					
		 	Grant Date:	 	August 24, 2018
	            
	 	 Fair Value:
 Number of Restricted Stock
Units:
 Type of Award:
	 	 $2,000,000.00
 57,645 Units*

Restricted Stock Units released in shares of Common Stock

		 	Vesting Schedule:	 	The Grant will vest entirely on December 31, 2021

 * Based on the average of the high and low price of the Common Stock as reported on the New York Stock Exchange on the
Grant Date. 
 2. Terms and Conditions. To be eligible to receive the Grant: 

(a) Support of Leadership Transition Process. You must assist, support and fully cooperate with Weyerhaeuser and the other members of
the senior leadership team in all matters relating to the leadership transition. You must perform all tasks requested of you by your manager or such other officers as they may request to effect an orderly transition of leadership at Weyerhaeuser.

  
 1 

 (b) No Violation. You must have complied with all of the provisions of this Agreement
and the Additional Terms and Conditions (as defined and set forth below) through the Vesting Date (as defined below). 
 3. Additional Terms and
Conditions. In addition to the terms and conditions of this Agreement, the Grant is also subject to all of the terms and conditions set forth in the 2019 Restricted Stock Unit Award Terms and Conditions attached hereto as Appendix
A and applicable provisions in the Plan (collectively, the “Additional Terms and Conditions). The Additional Terms and Conditions are incorporated into this Agreement by reference and made a part hereof. 

4. Employment at Will. Your employment with Weyerhaeuser will continue to be “at will.” This means that your employment may be terminated at
any time by you or by Weyerhaeuser. The Grant does not alter the “at will” basis of your employment and neither binds you to continued employment nor confers any rights to you with respect to continuation of your employment. 

5. Governing Law and Venue. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Washington
applicable to contracts made and to be performed within such state without regard to its conflict of law rules. Each party to this Agreement submits to the exclusive jurisdiction of any state or federal court sitting in King County, Washington or
the Western District of Washington, respectively, in any action or dispute arising out of or relating to this Agreement and agrees that all claims in respect of such action or dispute shall be heard and determined in any such court. Each party also
agrees not to bring any action or proceeding arising out of or relating to this agreement in any other court and waives any defense or objection to the jurisdiction of any such court, including that of inconvenient forum. 

6. Other Provisions. In the event that any provision of this Agreement, the Additional Terms and Conditions shall be held illegal or invalid for any
reason, such illegality or invalidity shall not affect the remaining parts of this Agreement or the Additional Terms and Conditions, as the case may be, and this Agreement and the Additional Terms and Conditions shall be construed and enforced as if
the illegal or invalid provision had not been included. No provision of this Agreement or the Additional Terms and Conditions may be modified, waived, or discharged unless such modification, waiver, or discharge is agreed to in writing and signed by
you and by a duly authorized officer of Weyerhaeuser (or its subsidiary), or by the respective parties’ legal representatives and successors. 
 If the
terms of this Agreement (including the Additional Terms and Conditions) are agreeable to you, please sign in the space indicated below and return your signed original to me. 

I want to thank you for your support and continued service to Weyerhaeuser. 

Sincerely, 
  

	
	 /s/ Denise M. Merle

	 Denise M. Merle

	 Senior Vice President, Chief Administration Officer

 I, Adrian M. Blocker, have read, understand and agree to the terms and conditions of this Agreement. 

 

	
	/s/ Adrian M. Blocker
	Date: August 24, 2018
	Adrian M. Blocker

  
 2 

 APPENDIX A 

RESTRICTED STOCK UNIT AWARD 

ADDITIONAL TERMS AND CONDITIONS 
 Pursuant
to the letter agreement dated as of August 24, 2018 (“Agreement”) to which these Additional Terms and Conditions are appended, incorporated by reference and made a part thereof, Weyerhaeuser Company has offered to you the Grant
as specifically set forth in the Agreement. The Grant was made as of the date of the Compensation Committee action authorizing the Grant (“Grant Date”). You may decline the Grant by notifying the Compensation and Benefits Department
at bened@weyerhaeuser.com within one month of the Grant Date. If you decline the Grant, you will not be entitled to any award, benefit, or other compensation in lieu thereof. 

Capitalized terms used but not defined in this Additional Terms and Conditions document have the definitions given to such terms in the Agreement or in the
Plan, as the case may be. The Grant represents the Company’s unfunded and unsecured promise to issue shares of Company Common Stock to you at a future date in connection with vesting of restricted stock units, subject to the terms of this
Additional Terms and Conditions document and the Agreement. You have no rights to or under the Grant other than the rights of a general unsecured creditor of the Company. In addition, the Grant has the following terms and conditions: 

1. Vesting. Subject to (a) satisfaction of the terms and conditions set forth in Section 2 of the Agreement and (b) the provisions
of Section 3 of this Additional Terms and Conditions document, the Grant shall vest entirely on December 31, 2021 (“Vesting Date”), and no portion of the Grant shall vest prior to the Vesting Date. Prior to the Vesting
Date, the Grant is subject to forfeiture as set forth in Section 2 of the Agreement and Section 3 of this Additional Terms and Conditions document. 

2. Conversion of Awards and Issuance of Shares. Upon vesting of the Grant in accordance with Section 1, one share of Common Stock shall be
issued for each restricted stock unit of the Grant (“Shares”), subject to the terms of the Agreement and the Additional Terms and Conditions. The Company will subtract from the Shares the whole number of Shares necessary to satisfy
any required Tax Withholding Obligations, as described in Section 9, and transfer the balance of the Shares to you. No fractional shares of Common Stock shall be issued under the Grant. The issuance and delivery of Shares in connection with the
vesting of the Grant shall occur as soon as practicable after the Vesting Date (or, if applicable, the payment date specified in Section 3), but in all events by a date which is within 30 days following the Vesting Date (or such other payment
date, if applicable). 
 3. Termination of Employment; Death; Disability; Change in Control. In the event of your termination of employment,
death or Disability or a Change in Control while the Grant remains outstanding, the following vesting and payment provisions will apply. Within 30 days following each applicable payment date specified below, the Shares will be issued and paid to you
in accordance with and subject to Section 2. 

  
 A 1 

 (a) Termination of Employment Due to Job Elimination; Other Termination. If your
employment is involuntarily terminated due to (i) the elimination of your position with the Company or any Related Company or (ii) circumstances not otherwise contemplated, covered by or subject to subsections (b), (c) or (d) of this
Section 3, then 100% of the Grant will be immediately vested as of the effective time of such termination, the payment date shall be the Vesting Date, and all of the Shares with respect to the Grant will be issued and paid to you in accordance
with and subject to Section 2. 
 (b) Termination of Employment for Cause. If your employment is terminated for Cause
(defined below), then notwithstanding anything to the contrary herein, 100% of the Grant shall be forfeited immediately at the time the Company or Related Company first notifies you of your termination for Cause and no Shares will be issued or
issuable, or paid or payable, with respect to the Grant. In addition, if your employment or service relationship is suspended pending an investigation of whether you will be terminated for Cause, issuance and payment of Shares in connection with the
Grant may be suspended during such period of investigation to the extent that any delay does not result in additional tax imposed under Section 409A of the U.S. Internal Revenue Code of 1986, as amended
(“Section 409A”). If, at the conclusion of such investigation, your employment or service relationship is terminated for Cause, 100% of the Grant shall be forfeited as provided above and no Shares will be issuable
or payable with respect to the Grant. 
 “Cause” means: (i) willful and continued failure to perform substantially your duties with the
Company or any Related Company after the Company or Related Company delivers to you written demand for substantial performance specifically identifying the manner in which you have not substantially performed your duties; (ii) conviction of a
felony; (iii) willfully engaging in illegal conduct or gross misconduct; or (iv) a material breach or violation of Weyerhaeuser policy. 

(c) Death or Disability. In the event of your death or Disability while actively employed with the Company or any Related Company,
100% of the Grant will be immediately vested as of the time of such event, the payment date shall be the date of such death or Disability, and Shares will be issued and paid to you or to your estate, as the case may be, in accordance with and
subject to Section 2. “Disability” means a “disability” as defined in Treas. Reg. § 1.409A-3(i)(4) (or successor provisions). 

(d) Change in Control. The following provisions shall apply in the event of a Change in Control: 

(i) If the Grant is not assumed, converted or replaced by the acquiring company to the Company, the Grant will immediately vest in full as of
the effective date of the Change in Control and shall be converted to a non-forfeitable right to receive an amount in cash equal to the Fair Market Value of one share of Common Stock on the date of the Change
in Control multiplied by the number of Shares relating to the Grant. The amount shall be accumulated with interest compounded annually from the date of the Change in Control until the payment is made at a rate of 120 percent of the Federal mid-term rate (as in 

  
 A 2 

 
effect under section 1274 of the Code for the month in which the Change in Control occurs). The payment date shall be the Vesting Date or, if earlier, the date of your separation from service
that occurs within two years following a 409A Change in Control. Such payment shall be paid to you in accordance with and subject to Section 2 (except that payment shall be made in cash rather than Shares). 

(ii) If the Grant is assumed, converted or replaced by the acquiring company and prior to the Vesting Date your employment is either
involuntarily terminated without Cause or voluntarily terminated by you for Good Reason, then in each case 100% of the Grant will be immediately vested as of the date of your termination of employment, the payment date shall be the date of such
separation from service (except that, if the separation from service does not occur within two years following a 409A Change in Control, the payment date shall be the Vesting Date), and all of the Shares with respect to the Grant will be issued and
paid to you in accordance with and subject to Section 2. 
 For purposes of this Section 3(d), a separation from service by the Company includes a
separation from service by any Related Company and any successor entity, and a “409A Change in Control” means a Change in Control that qualifies as a “change in control event” for purposes of Treas. Reg. § 1.409A-3(i)(5). 
 “Good Reason” means, without your express written consent, the occurrence of any one or more
of the following events: 
 i. a material reduction in your authority, duties, or responsibilities existing immediately prior to the
Change in Control; 
 ii. within two years following a Change in Control, the acquiring company requiring you to be based at a
location that is at least 50 miles farther from your primary residence immediately prior to a Change in Control than is such residence from Weyerhaeuser’s headquarters immediately prior to a Change in Control, except for required travel on the
acquiring company’s business to an extent substantially consistent with your business obligations as of the Grant Date; 
 iii. a
material reduction by the acquiring company of your base salary as in effect immediately prior to the Change in Control; 
 iv. a
material reduction in the benefits coverage in the aggregate provided to you immediately prior to the Change in Control; provided, however, that reductions in the level of benefits coverage will not be deemed to be “Good Reason” if your
overall benefits coverage is substantially consistent with the average level of benefits coverage of other executives who have positions commensurate with your position at the acquiring company; or 

v. a material reduction in your level of participation, including your target-level opportunities, in short- and/or long-term incentive
compensation plans in which you participate as of the Grant Date (for this purpose a material reduction shall be deemed to have occurred if the aggregate “incentive opportunities” are reduced by 10% or more), or

  
 A 3 

 
a material increase in the relative difficulty of the measures used to determine the payouts under such plans; provided, however, that reductions in the levels of participation or increase in
relative difficulty of payout measures will not be deemed to be “Good Reason” if your reduced level of participation or difficulty of measures in each such program remains substantially consistent with the level of participation or
difficulty of the measures of some or all other executives who have positions commensurate with your position at the acquiring company. 
 In no event will
your resignation be for Good Reason unless: (A) an event set forth above has occurred and you provide the acquiring company with written notice thereof within 30 days after you have knowledge of the occurrence or existence of such event, which
notice specifically identifies the event that you believe constitutes Good Reason; (B) the acquiring company fails to correct the event so identified in all material respects within 30 days after receipt of such notice; and (C) you resign
within two years after the occurrence of such event. 
 (e) Voluntary Termination of Employment. If your
employment is terminated by you before the Grant is vested in accordance with Section 1, including without limitation by reason of voluntary retirement, and none of the other provisions of this Section 3 apply, then 100% of the Grant shall
be forfeited and no Shares shall be issued or issuable, or paid or payable, with respect to the Grant. 
 4. Dividends. Except as otherwise
specifically provided in this Additional Terms and Conditions document, you will not be entitled to any rights of a shareholder with respect to the Grant. Notwithstanding the foregoing, if the Company declares and pays dividends on Common Stock
during the time period when the Grant is outstanding, you will be credited with additional amounts for each restricted stock unit of the Grant equal to the dividend that would have been paid with respect to such restricted stock unit if it had been
an actual share of Common Stock. Such credited dividend amounts shall be reinvested in additional restricted stock units, which additional restricted stock units shall be subject to the same vesting, payment and other provisions as are applicable to
the restricted stock units underlying the Grant. 
 5. No Rights as Shareholder until Vesting and Issuance of Shares. You will not have any
voting or any other rights as a shareholder of the Common Stock with respect to the restricted stock units of the Grant. Upon vesting of the Grant and issuance and payment of the Shares, you will obtain full voting and other rights as a shareholder
of the Company. 
 6. Securities Law Compliance. Notwithstanding any other provision of this document, you may not sell the Shares acquired
upon vesting of the Grant unless such Shares are registered under the Securities Act of 1933, as amended (the “Securities Act”), or, if such Shares are not then so registered, such sale is exempt from the registration requirements
of the Securities Act. The sale of such Shares must also comply with other applicable laws and regulations governing the Shares and you may not sell the Shares if the Company determines that such sale would not be in material compliance with such
laws and regulations. 

  
 A 4 

 7. Non-Transferability of Awards. Notwithstanding any
other provision of this document, you may not sell, pledge, assign, hypothecate, transfer or dispose of the Grant in any manner prior to any distribution to you of the Shares. The Grant shall not be subject to execution, attachment or other process.
Notwithstanding the foregoing, pursuant to Section 3(c), Shares may be issued and paid to your estate in the event of your death. 
 8.
Independent Tax Advice. Determining the actual tax consequences of receiving or disposing of the Shares may be complicated. These tax consequences will depend, in part, on your specific circumstances and also may depend on the resolution of
currently uncertain tax law and other variables not within the control of the Company. You should consult a competent and independent tax advisor for a full understanding of the specific tax consequences to you of receiving or disposing of the
Shares. You are encouraged to consult with a competent tax advisor independent of the Company to obtain tax advice concerning any vesting of the Grant or any receipt or disposition of the Shares in light of your specific circumstances. 

9. Taxes and Withholding. You are ultimately liable and responsible for all taxes owed in connection with the Grant, including federal, state,
local, FICA, or foreign taxes of any kind required by law, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Grant. The Company makes no representation or undertaking
regarding the treatment of any tax withholding in connection with the Grant or vesting thereof or the subsequent sale of Shares issuable and payable pursuant to the Grant. The Company does not commit and is under no obligation to structure the Grant
to reduce or eliminate your tax liability. When an event occurs in connection with the Grant (e.g., vesting) that the Company determines results in any domestic or foreign tax withholding obligation, whether national, federal, state or local,
including any social tax obligation (a “Tax Withholding Obligation”), to the extent required by law, and to the extent permitted by Section 409A, the Company may retain without notice from any Shares issuable under the Grant or
from salary or other amounts payable to you, whole Shares or cash having a value sufficient to satisfy your Tax Withholding Obligation. 
 The Company may
refuse to issue any Shares to you until your Tax Withholding Obligation is satisfied. You should be aware that, in accordance with the Plan, a delay in satisfying your Tax Withholding Obligation could cause a forfeiture of the Shares. 

10. Grant Not an Employment or Service Contract. Nothing in the Plan or any Award granted under the Plan, including the Grant, will be deemed to
constitute an employment contract or confer or be deemed to confer any right for you to continue in the employ of, or to continue any other relationship with, the Company or any Related Company or limit in any way the right of the Company or any
Related Company to terminate your employment or other relationship at any time, with or without cause. 
 11. No Right to Damages. You will
have no right to bring a claim or to receive damages if any portion of the Grant is forfeited. The loss of existing or potential profit in the Grant or any Shares that would have been issued and paid in connection therewith will not constitute an
element of damages in the event of your termination of service for any reason even if the termination is in violation of an obligation of the Company or a Related Company to you. 

  
 A 5 

 12. Binding Effect. The terms and conditions of the Grant will inure to the benefit of the
successors and assigns of the Company and be binding upon you and your heirs, executors, administrators, successors and assigns. 
 13. Limitation
on Rights; No Right to Future Grants; Extraordinary Item of Compensation. (a) All Awards under the Plan are discretionary in nature and may be suspended or terminated by the Company at any time. (b) Each grant of an Award is a one-time benefit that does not create any contractual or other right to receive future grants of Awards. (c) All determinations with respect to any such future grants, including but not limited to, the times
when grants will be made, the number of Awards subject to each grant, the grant price, vesting and other terms applicable to the grant, and the time or times when each grant will be exercisable, will be at the sole discretion of the Company.
(d) Your participation in the Plan is voluntary. (e) The value of the Grant is an extraordinary item of compensation that is outside the scope of your employment contract, if any. (f) The Grant is not part of normal or expected
compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. (g) Except as may otherwise be explicitly provided in
the terms and conditions of the Grant, the vesting of the Grant ceases upon your termination of employment for any reason and any unvested portion of the Grant will be forfeited. (h) The future value of the Shares underlying the Grant is
unknown and cannot be predicted with certainty. 
 14. Employee Data Privacy. By accepting the Grant, you: (a) authorize the Company and
your employer, if different, and any agent of the Company administering the Plan or providing Plan recordkeeping services, to disclose to the Company or any of its affiliates, and their respective agents in connection with administering the Plan,
any information and data the Company requests (including personal data) in order to facilitate the grant of the Award and the administration of the Plan; (b) agree that the Company (and your employer, if different, and any of their respective
agents in connection with administering the Plan) may act as a data controller and/or data processor with respect to such information and data and waive to the maximum extent permissible by law any data privacy rights you may have with respect to
such information and data; and (c) authorize the Company and its agents to store and transmit such information, including in electronic form, to its affiliates or agents in any country (including countries which may not provide for data
protection equivalent to the United States). 
 15. Compliance with Section 409A. The Grant is intended to comply with
Section 409A. However, neither Weyerhaeuser nor any subsidiary or affiliate of Weyerhaeuser will have any obligation to indemnify or otherwise hold you harmless from any additional taxes or penalties under Section 409A. To the extent that
the Company determines that the Grant is subject to Section 409A, the Agreement and this Additional Terms and Conditions document will be interpreted and administered in such a way as to comply with the applicable provisions of
Section 409A to the maximum extent possible. In addition, if you must be treated as a “specified employee” within the meaning of Section 409A, any payments made on account of your separation from service for purposes of
Section 409A will be made at the times specified above in this Additional Terms and Conditions document or, if later and to the extent required by 

  
 A 6 

 
Section 409A, on the date that is six months and one day following the date of your separation from service. When the period during which payment may be made straddles two taxable years, in
no event are you permitted, directly or indirectly, to designate the taxable year of any payment. To the extent that the Company determines that the Grant is subject to Section 409A and fails to comply with the requirements of
Section 409A, the Company reserves the right (without any obligation to do so) to amend, restructure, terminate or replace the Grant in order to cause the Grant to either not be subject to Section 409A or to comply with the applicable
provisions of Section 409A. 

  
 A 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}]]